Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Previous studies suggested that asymmetric stent expansion did not affect suppression of neointimal hyperplasia (NIH) after sirolimus-eluting stents (SES) implantation. The aim of this study was to evaluate the effects of stent eccentricity (SE) on NIH between SES versus paclitaxel-eluting stents (PES)using an intravascular ultrasound (IVUS) analysis from the randomized trial. Materials and Methods: Serial IVUS data were obtained from Post-stent Optimal Expansion (POET) trial, allocated randomly to SES or PES. Three different SE (minimum stent diameter divided by maximum stent diameter) were evaluated;SE at the lesion site with maximal %NIH area (SE-NIH), SE at the minimal stent CSA [SE-minimal stent area (SE-MSA)], and averaged SE through the entire stent (SE-mean). We classified each drug-eluting stents (DES) into the concentric (≥ mean SE) and eccentric groups (< mean SE) based on the mean value of SE. Results: Among 301 enrolled patients, 233 patients [SES (n = 108), PES (n =125)] underwent a follow-up IVUS. There was no significant correlation between %NIH area and SE-NIH (r = - 0.083, p = 0.391) or SE-MSA (r = - 0.109, p =0.259) of SES. However, SE-NIH of PES showed a weak but significant correlation with %NIH area (r = 0.269, p < 0.01). As to the associations between SEmean and NIH volume index, SES revealed no significant correlation (r = - 0.001,p = 0.990), but PES showed a weak but significant correlation (r = 0.320, p <0.01). However, there was no difference in the restenosis rate between the eccentric versus concentric groups of both DES. Conclusion: This study suggests that lower SE of both SES and PES, which means asymmetric stent expansion, may not be associated with increased NIH.
Abstract
Purpose: Previous studies suggested that asymmetric stent expansion did not affect suppression of neointimal hyperplasia (NIH) after sirolimus-eluting stents (SES) implantation. The aim of this study was to evaluate the effects of stent eccentricity (SE) on NIH between SES versus paclitaxel-eluting stents (PES)using an intravascular ultrasound (IVUS) analysis from the randomized trial. Materials and Methods: Serial IVUS data were obtained from Post-stent Optimal Expansion (POET) trial, allocated randomly to SES or PES. Three different SE (minimum stent diameter divided by maximum stent diameter) were evaluated;SE at the lesion site with maximal %NIH area (SE-NIH), SE at the minimal stent CSA [SE-minimal stent area (SE-MSA)], and averaged SE through the entire stent (SE-mean). We classified each drug-eluting stents (DES) into the concentric (≥ mean SE) and eccentric groups (< mean SE) based on the mean value of SE. Results: Among 301 enrolled patients, 233 patients [SES (n = 108), PES (n =125)] underwent a follow-up IVUS. There was no significant correlation between %NIH area and SE-NIH (r = - 0.083, p = 0.391) or SE-MSA (r = - 0.109, p =0.259) of SES. However, SE-NIH of PES showed a weak but significant correlation with %NIH area (r = 0.269, p < 0.01). As to the associations between SEmean and NIH volume index, SES revealed no significant correlation (r = - 0.001,p = 0.990), but PES showed a weak but significant correlation (r = 0.320, p <0.01). However, there was no difference in the restenosis rate between the eccentric versus concentric groups of both DES. Conclusion: This study suggests that lower SE of both SES and PES, which means asymmetric stent expansion, may not be associated with increased NIH.
참고문헌 (18)
- Kataoka T, "7-hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE)", Circulation, 106, pp.1788~1793 (2002)
- Park SJ, "A paclitaxel-eluting stent for the prevention of coronary restenosis", N Engl J Med, 348, pp.1537~1545 (2003)
- Lambert TL, "Localized arterial wall drug delivery from a polymer-coated removable metallic stent. Kinetics, distribution, and bioactivity of forskolin", Circulation, 90, pp.1003~1011 (1994)
- Hwang CW, "Physiological transport forces govern drug distribution for stent-based delivery", Circulation, 104, pp.600~605 (2001)
- Lansky AJ, "Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial", Circulation, 109, pp.1948~1954 (2004)
- Moses JW, "Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery", N Engl J Med, 349, pp.1315~1323 (2003)
- Kaneda H, "Impact of asymmetric stent expansion on neointimal hyperplasia following sirolimus-eluting stent implantation", Am J Cardiol, 96, pp.1404~1407 (2005)
- ), "Am J Cardiol", 2008, 304~310
- de Jaegere P, "Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study)", Eur Heart J, 19, pp.1214~1223 (1998)
- Nakano M, "Impact of highly asymmetric stent expansion after sirolimuseluting stent implantation on twelve-month clinical outcomes", J Cardiol, 49, pp.313~321 (2007)
- Mintz GS, "Intravascular ultrasound in the drugeluting stent era", J Am Coll Cardiol, 48, pp.421~429 (2006)
- Sonoda S, "Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the Sirius trial", J Am Coll Cardiol, 43, pp.1959~1963 (2004)
- Hong MK, "Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation", Eur Heart J, 27, pp.1305~1310 (2006)
- Takebayashi H, "Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation", Circulation, 110, pp.3430~3434 (2004)
- Hasegawa T, "Comparison of nonuniform strut distribution between two drugeluting stent platforms", J Invasive Cardiol, 19, pp.244~246 (2007)
- Opolski MP, "Stent strut distribution at implantation and 9-month follow-up in TAXUS and bare metal stents and its effect on neointimal hyperplasia", J Am Coll Cardiol, 53, pp.A9~ (2009)
- Otake H, "Local determinants of thrombus formation following sirolimuseluting stent implantation assessed by optical coherence tomography", JACC Cardiovasc Interv, 2, pp.459~466 (2009)
- 김웅, "The Initial Extent of Malapposition in ST-Elevation Myocardial Infarction Treated with Drug-Eluting Stent: The Usefulness of Optical Coherence Tomography", Yonsei Medical Journal, 51(3), pp.332~338 (2010), 연세대학교의과대학